Canaccord raised the firm’s price target on HealthStream to $28 from $27 and keeps a Hold rating on the shares. The firm said results indicated steady performance despite two headwinds including one-time items which negatively impacted financial performance and the bankruptcy of Steward Health.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSTM: